Recombinant human thymosin 4 (rht4) modulates the anti-inflammatory responses to alleviate benzalkonium chloride (bac)-induced dry eye disease

HIGHLIGHTS

  • who: Yanfang Zhai and collaborators from the Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, ChinaEye Institute of Xiamen University and Fujian Provincial Key Laboratory of Ophthalmology and Visual Science have published the article: Recombinant Human Thymosin 4 (rhT4) Modulates the Anti-Inflammatory Responses to Alleviate Benzalkonium Chloride (BAC)-Induced Dry Eye Disease, in the Journal: (JOURNAL)
  • what: The aim of this study was to investigate the ability of human thymosin u03b24 (rhTu03b24) to promote healing in a benzalkonium chloride (BAC)-induced mice DED model and the anti-inflammatory effects involved in that . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?